CIK 0001410098 · Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-12 | David Matthew T Chief Financial Officer | Grant or award | +50,000 | 53,150 | ||
| 2024-01-12 | David Matthew T Chief Financial Officer | Shares withheld for taxes | −5,216 | $3.47 | $18K | 47,934 |
| 2024-01-12 | David Matthew T Chief Financial Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +100,000 | 100,000 | ||
| 2024-01-12 | Mistry Erin Chief Commercial Officer | Grant or award | +50,000 | 54,900 | ||
| 2024-01-12 | Mistry Erin Chief Commercial Officer | Shares withheld for taxes | −4,389 | $3.47 | $15K | 50,511 |
| 2024-01-12 | Mistry Erin Chief Commercial Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +100,000 | 100,000 | ||
| 2024-01-12 | Todisco Joseph Chief Executive Officer | Grant or award | +133,333 | 353,059 | ||
| 2024-01-12 | Todisco Joseph Chief Executive Officer | Shares withheld for taxes | −13,781 | $3.47 | $48K | 339,278 |
| 2024-01-12 | Todisco Joseph Chief Executive Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +266,667 | 266,667 | ||
| 2023-12-15 | DUNTON ALAN W Director | Purchase | +3,000 | $3.30 | $10K | 15,250 |
| 2023-12-14 | DUNTON ALAN W Director | Purchase | +3,000 | $3.45 | $10K | 12,250 |
| 2023-12-12 | Zelnick Kaufman Beth Chief Legal Officer | Grant or award | +50,000 | 50,000 | ||
| 2023-12-12 | Zelnick Kaufman Beth Chief Legal Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +200,000 | 200,000 | ||
| 2023-11-17 | Mistry Erin Chief Commercial Officer | Purchase | +1,000 | $4.00 | $4K | 4,900 |
| 2023-11-16 | Lefkowitz Steven W Director | Option exercise | +15,000 | $2.25 | $34K | 75,498 |
| 2023-11-16 | Lefkowitz Steven W Director | Option exercise · Stock Option (Right to Buy Common Stock) | −15,000 | 0 | ||
| 2023-09-08 | Todisco Joseph Chief Executive Officer | Purchase | +10,000 | $3.71 | $37K | 219,726 |
| 2023-05-18 | Kaplan Myron Director | Purchase | +6,000 | $4.54 | $27K | 166,034 |
| 2023-05-17 | Costa Paulo F Director | Purchase | +10,000 | $4.65 | $47K | 10,000 |
| 2023-05-17 | DUNTON ALAN W Director | Purchase | +3,000 | $4.33 | $13K | 9,250 |
Page 8 of 9 · 176 trades